Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fortress Biotech, Inc. | 1,248,604 | reported | 01 Oct 2025 | tx 10+2,544,116 |
| Avalon GloboCare Corp. | 400,000 | reported | 20 Feb 2020 | tx 1+400,000 |
| AVENUE THERAPEUTICS, INC. | 65,000 | reported | 23 Sept 2024 | tx 2+315,000 |
| MUSTANG BIO, INC. | 286 | reported | 30 Dec 2025 | tx 1+247 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Dec 2025 | PURCHASE | MUSTANG BIO, INC. | 247 | 0.96 USD | first after silence |
| 01 Oct 2025 | GRANT_AWARD | Fortress Biotech, Inc. | 2,711 | 1.31 USD | |
| 01 Apr 2025 | GRANT_AWARD | Fortress Biotech, Inc. | 5,000 | 1.22 USD | |
| 19 Dec 2024 | GRANT_AWARD | Fortress Biotech, Inc. | 1,000,000 | 0.00 USD | |
| 01 Oct 2024 | GRANT_AWARD | Fortress Biotech, Inc. | 2,625 | 1.23 USD | |
| 23 Sept 2024 | GRANT_AWARD | AVENUE THERAPEUTICS, INC. | 65,000 | 0.00 USD | |
| 10 Jul 2024 | PURCHASE | Fortress Biotech, Inc. | 500 | 7.50 USD | first after silence |
| 01 Apr 2024 | GRANT_AWARD | Fortress Biotech, Inc. | 2,352 | 1.70 USD | |
| 20 Dec 2023 | GRANT_AWARD | Fortress Biotech, Inc. | 140,000 | 0.00 USD | |
| 30 Jun 2023 | GRANT_AWARD | AVENUE THERAPEUTICS, INC. | 250,000 | 0.00 USD | deriv |
| 10 Feb 2023 | PURCHASE | Fortress Biotech, Inc. | 35,928 | 0.84 USD | |
| 30 Nov 2022 | PURCHASE | Fortress Biotech, Inc. | 5,000 | 0.56 USD | |
| 26 Oct 2022 | GRANT_AWARD | Fortress Biotech, Inc. | 1,350,000 | 0.00 USD | |
| 20 Feb 2020 | GRANT_AWARD | Avalon GloboCare Corp. | 400,000 | 1.52 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 30 Dec 2025.